The complicated world of neuroendocrine tumors (NETs) is the subject of this episode of Healthcare Unfiltered. Dr. Chadi Nabhan is joined by Pamela Kunz, MD, Director of the Center for GI Cancers at Yale Cancer Center and Vice Chief of Diversity, Equity, and Inclusion for medical oncology at Yale Cancer Center.
In their discussion, they shed light on the potential reasons for higher incidence of NETs in the past three decades, the boom of FDA approvals in the last decade, and the latest therapies and clinical trials with the most potential to move the needle for patient care.
Dr. Lunz also highlights the priorities of a new committee she has helped form for diversity, equity, and inclusion within the institution, including data collection, increasing the diversity of the faculty, and creating a culture of respect.
This episode originally appeared on chadinabhan.com.